Rewind Therapeutics

Rewind Therapeutics´ highly experienced, international team has established a leading-edge knowledge base in the field of remyelination. 

The Company aims to decipher and re-establish the process of remyelination in patients suffering from major neuronal diseases and injuries. Although the causes and types of demyelination vary, the repair process is identical and regarded as a necessary element for successful nerve protection therapy. This approach opens significant therapeutic potential for a broad range of demyelination-induced disease.

For more information, please contact:

Claus Andersson, PhD

General Partner

Phone: +45 2270 5065